PharmacoEconomics

The Role of Patient Preferences in Cost-Effectiveness Analysis: A Conflict of Values?
pp. 705-712(8)
Authors: Brazier, John E.; Dixon, Simon; Ratcliffe, Julie

Methods for Measuring Temporary Health States for Cost-Utility Analyses
pp. 713-723(11)
Authors: Wright, Davene R.; Wittenberg, Eve; Swan, J. Shannon; Miksad, Rebecca A.; Prosser, Lisa A.

Head Lice Treatments and School Policies in the US in an Era of Emerging Resistance: A Cost-Effectiveness Analysis
pp. 725-734(10)
Authors: Gur, Itzhak; Schneeweiss, Ronald

A Cost-Effectiveness Analysis to Illustrate the Impact of Cost Definitions on Results, Interpretations and Comparability of Pharmacoeconomic Studies in the US
pp. 735-744(10)
Author: Tunis, Sandra L.

Comparing Three Software Tools for Implementing Markov Models for Health Economic Evaluations
pp. 745-753(9)
Authors: Menn, Petra; Holle, Rolf

The Importance of Clinical Variables in Comparative Analyses Using Propensity-Score Matching: The Case of ESA Costs for the Treatment of Chemotherapy-Induced Anaemia
pp. 755-765(11)
Authors: Polsky, Daniel; Eremina, Daria; Hess, Gregory; Hill, Jerrold; Hulnick, Scott; Roumm, Adam; Whyte, Joanna L.; Kallich, Joel

Utilities of the EQ-5D: Transferable or Not?
pp. 767-779(13)
Authors: Knies, Saskia; Evers, Silvia M.A.A.; Candel, Math J.J.M.; Severens, Johan L.; Ament, André J.H.A.

Incremental 1-Year Medical Resource Utilization and Costs for Patients with Herpes Zoster from a Set of US Health Plans
pp. 781-792(12)
Authors: White, Ronald R.; Lenhart, Greg; Singhal, Puneet K.; Insinga, Ralph P.; Itzler, Robbin F.; Pellissier, James M.; Segraves, Arthur W.